Paeds Vivas · pain-palliative-and-end-of-life-care
Paediatric palliative care principles and referral — branching viva
Branching viva on the principles and referral of paediatric palliative care: the WHO definition and parallel-care model, the four Together for Short Lives (ACT) categories with worked examples, the Paediatric Palliative Screening Scale (PaPaS), the relationship between the palliative referral and the resuscitation decision, the under-recognised suffering of group 4 children, and bereavement follow-through.
On this page & tools
Target exams
Opening question
This 6-year-old with relapsed high-risk neuroblastoma has just been diagnosed, and the oncology team plans further intensive treatment. Tell me why you would refer him to the palliative care team today, what the WHO definition of paediatric palliative care is, and why referring only at end of life is the most common error in this field. [1] [5]
Branch 1 — the parallel-care model and the misconception
You have decided to refer at diagnosis. Explain the parallel-care model to the oncology fellow who worries this means giving up. Tell me how you would correct the misconception that palliative care replaces active treatment, and how you would explain the relationship between the palliative referral and any resuscitation or escalation decision. [2] [4]
Branch 2 — classifying the non-progressive child
Step sideways to a 4-year-old with severe cerebral palsy, non-verbal, admitted for the third time this year with aspiration pneumonia. Classify her under the Together for Short Lives (ACT) framework, give the defining features of that category, name another worked example, and tell me why suffering in this group is the most under-recognised in paediatrics. Now do the same for a boy with Duchenne muscular dystrophy. [10] [5]
Branch 3 — the PaPaS scale and the referral pathway
Describe the Paediatric Palliative Screening Scale (PaPaS) of Bergstraesser: what it scores, what it is for, and its relationship to the ACT categories. Walk me through the full referral and care pathway from identification through bereavement, and tell me who is in the multidisciplinary team. [8] [4]
Branch 4 — the four domains, settings and place of death
Tell me how you would assess this family across the four domains of suffering, why the family is the unit of care, and how you would elicit and support the preferred place of care and death. What does the evidence from Bluebond-Langner tell you about what shapes a family's preferred place of death? [4] [11]
Closing — bereavement follow-through
Six months after a child dies, the family has heard nothing from the team. Tell me why that is a core failure of palliative care, what a bereavement pathway should look like, and how you would close your viva with the single most important principle a general paediatrician should take away from this topic. [4] [11]
References
- [1]Wolfe J, Grier HE, Klar N, et al Symptoms and suffering at the end of life in children with cancer. N Engl J Med, 2000.PMID 10655532
- [2]Wolfe J, Hammel JF, Edwards KE, et al Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol, 2008.PMID 18375901
- [4]Section on Hospice and Palliative Medicine and Committee on Hospital Care Pediatric Palliative Care and Hospice Care Commitments, Guidelines, and Recommendations. Pediatrics, 2013.PMID 28448256
- [5]Himelstein BP, Hilden JM, Boldt AM, Weissman D Palliative care for infants, children, adolescents, and their families. J Palliat Med, 2006.PMID 16430356
- [8]Bergstraesser E, Hahn CP, Kaiser G, et al The Paediatric Palliative Screening Scale: Further validity testing. Palliat Med, 2014.PMID 24280277
- [10]Shaw KL, Brook L, Cuddeford L, et al The Spectrum of Children's Palliative Care Needs: a classification framework for children with life-limiting or life-threatening conditions. BMJ Support Palliat Care, 2015.PMID 24644200
- [11]Bluebond-Langner M, Beecham E, Candy B, et al Preferred place of death for children and young people with life-limiting and life-threatening conditions: a systematic review of the literature and recommendations for future inquiry and policy. Palliat Med, 2013.PMID 23612958